À propos de nous
Our Journey
Adheron Therapeutics began with a small team of passionate scientists dedicated to unraveling the complexities of cell adhesion pathways. From humble beginnings in experimental labs, we rapidly established a reputation for innovation and impactful research. Driven by collaboration and a relentless commitment to science, we have grown into a leader in therapeutic development, advancing solutions for fibrotic and autoimmune diseases.
Redefining modern biotechnology
Our mission is clear: to transform lives through groundbreaking research and innovative therapies. Every study we undertake connects directly to real-world challenges, combining cutting-edge methodologies with tangible applications. At Adheron Therapeutics, our focus is not only on publishing research but ensuring it drives meaningful, lasting impact in healthcare.
#InnovateForHealth
Meet our Experts
Dr. Tony Cartez
Dr. Tony Cartez is renowned for his groundbreaking research in gene editing and has received numerous accolades for his contributions to the field. he also leads a team dedicated to developing sustainable bioproducts.
Dr. Emily Carter
Renowned for her pioneering work in gene editing and sustainable bioproducts, Dr. Carter leads innovative research teams and has received numerous accolades for her contributions to science.
Dr. Mich Starck
With over 50 groundbreaking studies and multiple patents, Dr. Starck is a recognized innovator in biotechnology, awarded top honors by BioWorld.
Dr. Aline Kim
A thought leader in biotechnology, Dr. Kim was named one of the most influential figures in science by Scientific American. Her expertise in genetic research continues to shape the field.